Navigation Links
CRH provides Partnership Program update
Date:2/24/2009

VANCOUVER, Feb. 24 /PRNewswire-FirstCall/ - CRH Medical Corporation announced today that through its Partnership Program, the CRH O'Regan Hemorrhoid banding technology has been adopted by more than 90% of the gastroenterologist practice groups trained by the Company since June 2008. The Company believes this provides clear evidence of not only a strong medical need, but also confirmation of the consistency of its training methodology. The sharing of knowledge and experience from our CRH Centers for Colorectal Health to individual physicians through our Partnership Program has gone smoothly, with continued high levels of safety and successful treatment outcomes.

The Company has now trained over two hundred physicians representing over 40 practice groups in 30 markets across the United States. The diagnosis of hemorrhoids requiring treatment during colonoscopy is very common. The CRH technology provides physicians with an effective modality to treat hemorrhoidal disease. It is clear by the significant adoption rate amongst physicians that the treatment of hemorrhoids is a natural extension of their practice. With over 8,000 gastroenterologists in the U.S. alone, the Company expects to significantly increase its efforts under the Partnership Program.

Commenting on the success of the Partnership Program, Edward Wright, Chief Executive of CRH said, "I am delighted to report that our new physician partners are reporting the same outstanding clinical outcomes that we experienced in treating over 50,000 hemorrhoids in our own Centers in the U.S." Wright further stated, "The Company expects to train in excess of 75 physicians in approximately 20 practices groups during the first quarter of 2009."

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technolog
'/>"/>

SOURCE CRH Medical Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2013)... People in Minnesota have a great option ... offering its 28 Day Fat Loss Formula. The best ... of their own home. The product sells for $135 dollars ... be accessed here: http://altmanfitness.com/28-day-fat-loss-formula/ , “Bikini season is ... now, but after using the 28 Day Fat Loss Formula ...
(Date:5/19/2013)... New York, New York (PRWEB) May 19, 2013 ... move forward in a federal litigation now underway in ... to a Case Management Order dated May 3rd, the ... the Bellwether Nominee Pool to eight cases rather than ... litigation is scheduled for Thursday, May 23rd. (In re: ...
(Date:5/19/2013)... Park City, Utah (PRWEB) May 19, 2013 ... new information on small business health insurance ... alternatives to traditional employer sponsored health benefits, is ... contribution and health reimbursement arrangements . ... businesses, start-ups, and the self-employed intrinsically know the ...
(Date:5/19/2013)... According to a new market research ... – 2018): By Applications (Healthcare (Endoscopy, Radiology, Ophthalmology), ... Contact IS, Infrared, X-Ray) And Geography" published by ... $8.00 billion in 2012 and is expected to ... CAGR of 3.84% from 2013 to 2018. In ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 These ... for US, UK, Spain, Japan, Italy, Germany and ... the molecular diagnostics laboratory practice, as well as ... with significant market impact during the next five ... probe and biochip technologies, test formats, detection methodologies, ...
Breaking Medicine News(10 mins):Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 2Health News:Zane Benefits Publishes New Information on Small Business Health Insurance 3Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 2Health News:Image Sensors Market to Reach $10.75 Billion by 2018 at a CAGR of 3.84% - New Report by MarketandMarkets 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4
... Drizzled with Pink White-Chocolate, CHICAGO, Oct. 8 ... announce its new Pink Ribbon Pretzel available throughout,October, ... resources and emotional support to those touched by,breast ... of,the breast cancer awareness ribbon, and topped with ...
... in the elderly increases the risk of subsequent mental ... intellectual decline, University of Rochester Medical Center psychiatrists and ... or prevention of depression would reduce or prevent cognitive ... that would be our hope, said Jeffrey M. Lyness, ...
... risk, experts say , , MONDAY, Oct. 8 (HealthDay News) -- ... fertilizer, according to a new study that finds human urine ... , The "yuck" factor aside, scientists who used urine to ... may not be a bad idea. , "Urine is a ...
... YORK, Oct. 8 Forest Laboratories, Inc.,(NYSE: ... pharmaceutical,products, will release its Fiscal 2008 Second Quarter ... Tuesday, October 16, 2007. Later that,day, at 10:00 ... where Dr. Lawrence,Olanoff, President and Chief Operating Officer ...
... busy fall season in,full swing, Hands2GO(R), the nation,s first ... against this year,s winter,cold and flu season. Typically, the ... "Regular hand washing, combined with Hands2GO hand sanitizers and ... year," said Francine,Glick, CEO and founder of Hands2GO. "It,s ...
... on the Internet: Thursday, October 11, 2007, 9 AM-4:00 PM, ... on employer-sponsored wellness programs that will work ... new economic model to address overweight and ... well as employers, e.g. Mayo Clinic, Hannaford ...
Cached Medicine News:Health News:Kim & Scott's Gourmet Pretzels(TM) Supports Breast Cancer Organizations With Its New Pink Ribbon Pretzel 2Health News:Depression can foreshadow intellectual decline in older people 2Health News:Human Urine Safe, Productive Fertilizer 2Health News:Human Urine Safe, Productive Fertilizer 3Health News:Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings 2Health News:Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work 2Health News:Hands2GO(R) Hand Sanitizer Offers Alcohol-Free Alternative to Stopping the Spread of Flu at School and Work 3Health News:Webcast Alert: Expert Group Urges Businesses to Get Real About Weight Loss 2
(Date:5/18/2013)... YORK , May 18, 2013 ... law firm, is investigating potential securities fraud at ... AVEO). (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... Company and its executives violated federal securities laws ... the Company,s Phase III drug trials for Tivopath ...
(Date:5/17/2013)... -- Medical devices are any medical items that are ... of their different mechanisms, actions and regulatory requirements, medical ... drug trails due to their unique clinical practices. Currently, ... both safety and efficacy (which is left to the ... as the SFDA) evaluate MDs for both safety and ...
(Date:5/17/2013)... 17, 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; ... Technology Small Business Technology Transfer Research (STTR) grant ... Infectious Diseases (NIAID), a division of the National ... novel human antibody therapeutics to combat Staphylococcus ... infections, including methicillin-resistant S. aureus (MRSA), ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Statistical Challenges in Medical Device Trail Evaluation 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4
... DALLAS , March 22 Texas Instruments Incorporated ... in a family of fully integrated analog front ends (AFEs) ... (EEG) equipment, as well as patient monitoring and consumer medical ... and power consumption by up to 95 percent as compared ...
... , March 22 Galderma Laboratories, L.P. today announced the U.S. Food and Drug Administration (FDA) approval of Differin® (adapalene) Lotion, 0.1%, ... April 2010 . , ... , ... ...
Cached Medicine Technology:Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 2Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 3Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 4Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 5Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 6Texas Instruments unveils fully integrated analog front end for ECG and EEG applications 7Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 2Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 3Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 4Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 5Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 6Galderma Received FDA Approval of Differin(R) (adapalene) Lotion, 0.1%, the First Retinoid Available in Lotion Formulation 7
... The instrument includes the ... has increased illumination for ... illumination. The Copeland retinoscope ... handle, and extended battery ...
... stereopsis from 800 to 40 ... young as 2 years of ... from left to right., ,Randot ... Book #1: 200 & 100 ...
... EasyEye is the only handheld non-contact tonometer with ... is streamlined, quiet and now, with constant ... a gentle puff of air. You can prove ... on the patient's hand before you start. ...
... 2000 Phenytoin Assay is a ... use in the quantitative analysis ... or plasma. Kits are packaged ... Roche COBAS MIRA, COBAS MIRA ...
Medicine Products: